Do you want to read an article? Please log in or register.
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
Pulmonary Fibrosis
RECOMMENDED
Related content
RECOMMENDED
Pulmonary Fibrosis
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Med.
Mondejar-Lopez P, Quintana-Gallego E, Giron-Moreno RM, Cortell-Aznar I, Ruiz de Valbuena-Maiz M, Diab-Caceres L, Prados-Sanchez C, Alvarez-Fernandez A, Garcia-Marcos PW, Peñalver-Mellado C, Pastor-Vivero MD, Olveira C, Lopez-Neyra A, Castillo-Corullon S, Palma-Milla S, Perez-Ruiz E, Sole-Jover A, Barrio MI, Sanchez-Solis M, Asensio de la Cruz Ó, CF-COVID19-Spain Registry Group
doi: 10.1016/j.rmed.2020.106062.
RECOMMENDED
Pulmonary Fibrosis
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Cyst Fibros.
Cosgriff R, Ahern S, Bell SC, Brownlee K, Burgel PR, Byrnes C, Corvol H, Cheng SY, Elbert A, Faro A, Goss CH, Gulmans V, Marshall BC, McKone E, Middleton PG, Ruseckaite R, Stephenson AL, Carr SB
doi: 10.1016/j.jcf.2020.04.012.
Pulmonary Fibrosis
The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network
J Cyst Fibros
Pearson K, Mayer-Hamblett N, Goss CH, Retsch-Bogart GZ, VanDalfsen JM, Burks P, Rosenbluth D, Clancy JP, Hoffman A, Nichols DP
doi: 10.1016/j.jcf.2020.12.007
RECOMMENDED
Pulmonary Fibrosis
SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros.
Berardis S, Verroken A, Vetillart A, Struyf C, Gilbert M, Gruson D, Gohy S
doi: 10.1016/j.jcf.2020.08.005.
RECOMMENDED
Pulmonary Fibrosis
Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Cyst Fibros
Bain R, Cosgriff R, Zampoli M, Elbert A, Burgel PR, Carr SB, Castaños C, Colombo C, Corvol H, Faro A, Goss CH, Gutierrez H, Jung A, Kashirskaya N, Marshall BC, Melo J, Mondejar-Lopez P, de Monestrol I, Naehrlich L, Pastor-Vivero MD, Rizvi S, Filho LVRFDS, Brownlee KG, Haq IJ, Brodlie M
doi: 10.1016/j.jcf.2020.11.021
RECOMMENDED
Respiratory Tract Infection
Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Infect Dis.
Tabata S, Imai K, Kawano S, Ikeda M, Kodama T, Miyoshi K, Obinata H, Mimura S, Kodera T, Kitagaki M, Sato M, Suzuki S, Ito T, Uwabe Y, Tamura K
doi: 10.1016/S1473-3099(20)30482-5.
Pulmonary Fibrosis
Impact of a cystic fibrosis transmembrane conductance regulator (CFTR) modulator on high-dose ibuprofen therapy in pediatric cystic fibrosis patients
Pediatr Pulmonol.
Bruch BA, Singh SB, Ramsey LJ, Starner TD
doi: 10.1002/ppul.24024.
RECOMMENDED
Pulmonary Fibrosis
The future of cystic fibrosis care: a global perspective
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med.
Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O'Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F
doi: 10.1016/S2213-2600(19)30337-6.
RECOMMENDED
Pneumonia
Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins
★ 1
Recommended by
Dr Martin Frey, Faculty Member
doi: 10.1038/s41586-020-2169-0.